Bank of New York Mellon
HUMA icon

Bank of New York Mellon’s Humacyte HUMA Stock Holding History

Bank of New York Mellon’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.6K Sell
55,844
-297,566
-84% -$276K ﹤0.01% 4246
2026
Q1 		$214K Buy
353,410
+9,659
+3% +$10K ﹤0.01% 3979
2025
Q4 		$330K Buy
343,751
+21,395
+7% +$30.3K ﹤0.01% 3815
2025
Q3 		$561K Buy
322,356
+23,758
+8% +$46.5K ﹤0.01% 3522
2025
Q2 		$624K Buy
298,598
+109,201
+58% +$210K ﹤0.01% 3387
2025
Q1 		$323K Sell
189,397
-2,983
-2% -$11.2K ﹤0.01% 3667
2024
Q4 		$972K Sell
192,380
-1,834
-0.9% -$9.07K ﹤0.01% 3182
2024
Q3 		$1.06M Sell
194,214
-59,799
-24% -$394K ﹤0.01% 3110
2024
Q2 		$1.22M Buy
254,013
+97,931
+63% +$510K ﹤0.01% 3079
2024
Q1 		$485K Sell
156,082
-20,270
-11% -$68.2K ﹤0.01% 3539
2023
Q4 		$501K Sell
176,352
-88,056
-33% -$226K ﹤0.01% 3548
2023
Q3 		$775K Buy
264,408
+3,302
+1% +$10.9K ﹤0.01% 3318
2023
Q2 		$747K Sell
261,106
-1,069
-0.4% -$3.85K ﹤0.01% 3380
2023
Q1 		$810K Sell
262,175
-5,532
-2% -$15.7K ﹤0.01% 3229
2022
Q4 		$565K Buy
267,707
+197,931
+284% +$601K ﹤0.01% 3482
2022
Q3 		$227K Buy
69,776
+13,536
+24% +$51.9K ﹤0.01% 3963
2022
Q2 		$180K Buy
56,240
+29,598
+111% +$165K ﹤0.01% 4095
2022
Q1 		$188K Buy
+26,642
New +$155K ﹤0.01% 4266

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
LWM
LJI Wealth Management Indianapolis, Indiana $714M AUM 21.51% 1-Year Est. Return

Bank of New York Mellon's HUMA Position: Q2 2026 in Review

Bank of New York Mellon reduced its Humacyte (HUMA) stake by 84% in Q2 2026, selling an estimated $276K and leaving 55,844 shares worth $43.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4246.

Bank of New York Mellon first reported a position in HUMA in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.22M in Q2 2024. 87 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Bank of New York Mellon held 55,844 shares of Humacyte worth $43.6K as of Q2 2026.
  • Bank of New York Mellon sold 297,566 Humacyte shares in Q2 2026, an estimated $276K.
  • Humacyte made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4246 holding.
  • Bank of New York Mellon first reported a position in Humacyte in Q1 2022 and has held it in 18 quarters since.
  • Bank of New York Mellon's Humacyte position peaked at $1.22M in Q2 2024.
  • 87 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.